Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

  • Rudolf A. Werner
  • , Harun Ilhan
  • , Sebastian Lehner
  • , László Papp
  • , Norbert Zsótér
  • , Imke Schatka
  • , Dirk O. Muegge
  • , Mehrbod S. Javadi
  • , Takahiro Higuchi
  • , Andreas K. Buck
  • , Peter Bartenstein
  • , Frank Bengel
  • , Markus Essler
  • , Constantin Lapa
  • , Ralph A. Bundschuh

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Neuroscience